Member Info for TrekMadone

230m MCAP is not enormous. Mr Market has a lot of catching up to do. This imo will soon be £2 and then £10 will not seem such a big deal. Just wait for our new Chinese factories to start chucking out nanene for batteries, clothes, tyres etc. Trek waiting for enormous.

I am surprised, I get VRS but I have always viewed Haydale as a piggy back consultancy and avoided. Pleased for investors there. Re the announcement good news for vrs and hayd coz big Cos often turn to little Cos to get things done quickly and there are some prominent MCAPs on the board. Trek

Yep but the accountant says 10years x 5 figures = 6 figures. Kidding. Still think this could be the lift now as hard cash should be trickling through and they wont need to go to the market for cash for a long time... Trek

Thats it. I was hoping for sub 60 to average down but I dont think well see that again now esp once folks tot up all the potential six figure deals! Time to add a few more. Trek

Good find and an interesting view. My opinion is that the world scale of the tyre market and that there are so many players will mean a lot of companies will evolve to meet the demand as the tech becomes adopted. It will become adopted and I guess now is the time to place bets. DCTAs retreading seems a great idea as it hits targets the commercial market and likewise the bike tyres are more on the performance side but there will be many winners and all the more losers in the graphene space. Trek

Thanks. The sales issues of last year have been resolved and I am confident in their business model especially tyres and grafysorber. This is interesting from GS today. It shows the potential for tech companies. The likes of VRS could if all goes well reach £100 a share or more if they follow the pattern of the likes of Microsoft. The scale is staggering which is why I have hedged some in DCTA the only other value producer as I see it. KR’s For a look at just how much technology dominates global markets, consider this: the market capitalization of the largest technology companies globally is now comparable to the annual GDP of Europe's largest economies. The top five US tech stocks have a combined market cap that exceeds the combined value of the 50 companies in the EuroStoxx index. Such growth might remind investors of the frenzied tech bubble of the 1990s, but today's technology gains have come on the back of growth in both revenue and profit margins that has far exceeded the market as a whole. "Margin expansion and stronger earnings have explained most of the returns in the technology sector in recent years," according to Goldman Sachs Research's Peter Oppenheimer. Trek

I firmly believe that VRS are the only ones capable of few layer graphene, Once the ISO standards are set I think there will be a shakeout. ......... DCTA also have single layer graphene. Check out their RNS today it gives a good summary. Holders of Vrs should do well to check out the competition. Trek holds both. GL

Great pre agm update today. Looks like we will be sat alongside VRS but still no VRS like rise. I have added here with confidence that our long overdue rerate will come. IMO this is a rare opportunity to get into this tech at such a low price. My average here is 50p and at VRS it’s 16p so I am expecting great things. Just patiently waiting for Mr Market to catch up. "It is testament to our position within the industry that the National Graphene Association, the main organisation and body in the US advocating and promoting the commercialisation of graphene and addressing critical issues such as standards and policy development, has invited Directa Plus to join as a new Corporate Partner and for Giulio Cesareo to join the Advisory Board. Trek

It is just so frustrating, one minute we are allegedly oversubscribed for placing shares the next minute the market cant absorb a few options that have been well guided to the market. I really dont think these brokers work hard enough for their money. These shares should be snapped up by an insti waiting on the sidelines. Oversubscribed heres your chance. Get your fingers out FinnC*ap! Carlsberg version, we have a load of options but dont worry there is a queue of instutional investors waiting for the shares and they have been sold to bla bla in a single OTC deal at a slight premium. Trek, money for old slopes!

Nice update yes at last BUT be careful BPC too many shares. Need to stop taking the lowest path of resistance now things are coming together. Getting financial buy in for exclusivity from the major was real out of the box thinking. More of that as we move forward please and less dilution. After nearly 8 years of patience let’s not dilute the little the long suffering have left. Trek patience and purgatory!

Arvind makes six million pairs of jeans every year using 100mln metres of fabric for household name brands such as Levi’s, Tommy Hilfilger, Wrangler and Gant and has established a reputation for innovation. We are expecting significant numbers year end. http://www.proactiveinvestors.co.uk/companies/stocktube/9282/directa-plus-to-add-graphene-enhancement-g-to-range-of-jeans-9282.html Looking forward to grafysorber phase 2 test results, must be due soon. Then commercials....DCTA heading right way slowly. Now IMO is time for longer term investors to add/buy. Trek

Wat forward is amore targeted medication based on DNA footprint rather than current broad brush approach. Helps mitigate side effects, efficacy and accuracy plus saves money. HZD should do well out of that thinking if they are around long enough! Trek

Added here. Looking to build sub 20p which looks to be where it is heading. Good work to those that topped up sub placing price. Trek, timing is everything!

Sure is a new model. Lots of upfront costs, tech, infrastructure, talent etc but over most of those hurdles now. Revenue through ticket sales and subs coming through, sponsorships are kicking off. Yep it�s a long one but growth potential is exponential. Good time to buy imo now. Trek and absolutely ask a teenager!

Oversubscribed at 62p no wonder. Getting fed up with this on AIM. I thought OPTI had a clear financial route to market. Theyre all the same! My av 76p so if such a good story why not raise at least at 70p and let the oversubscribed pay a reasonable price instead of a walked down VWAP before the strike price. What a useless broker! Trek it stinks!

We have crept up well of late and the Seed rise was mostly priced in following the leak. Annual results will be more about pointing to revenue source. The guidance is whats key. I think the market will remain agnostic until we announce a FCF number that will trigger a buying frenzy. No idea whatsoever what that tipping point is but at this level the investment case remains compelling. AIM has changed of late it really seems to be more results driven rather than potential and what ifs. Too many burnt PIs as it has become more accessible and there is easier money in the ft100. Trek, typing with a singed hand. Gla

I hope to add soon. Waiting for funds. Done me a favour coz I would have also added by now. But hey it could go either way. IMO we are moving into a higher low trading range now. Lot on atm but when I get time I will attempt to calc Charles St average. That will be a key number going forward as I think they have too much risk here so they may offload into newsflow. That could help save PIs with some risk management as buying now should be below the average. Trek.

Not seen Sunday Mail article but sounds like it was good press. Big spread here atm. Sp has pattern, it drops during day then closes unchanged. Been like it for weeks and massive price delays on google. When I have funds I will place an order at 48.85 see if it gets filled. If it doesnt I will just buy after a few days. Trek, nice to be ahead of the crowd for a change. I hope!

Could this lead to the long awaited re-rate? Probably as I will have funds in two weeks and thats how it goes! Well done DCTA, a fab signing. Only thing I am not clear on is what does exclusive mean? I trust its reach is just denim and not other apparel. Well I guess that would be the case as other g+ products are on the market. Trek. Time to catch VRS!

From proactive...On Stocktube, HemoGenyx Pharmaceuticals PLC (LON:HEMO) said it has entered into a collaboration agreement with Rockefeller University to use their new type of humanised mice for autoimmune disease modelling in an effort to develop new treatment for autoimmune diseases, specifically Lupus. Still long way to go to catch IMM. Trek... thinking of something profound to say. Profound profanity. GLA.